 Anna Peljto
Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 9 | 2023 | 505 | 1.780 |
Why?
| | Mucin-5B | 8 | 2023 | 183 | 1.290 |
Why?
| | Lung Diseases, Interstitial | 5 | 2024 | 508 | 0.800 |
Why?
| | Polymorphism, Genetic | 3 | 2016 | 610 | 0.700 |
Why?
| | Genetic Predisposition to Disease | 6 | 2023 | 2086 | 0.660 |
Why?
| | Scleroderma, Systemic | 2 | 2013 | 96 | 0.490 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 388 | 0.400 |
Why?
| | Pulmonary Fibrosis | 2 | 2016 | 323 | 0.360 |
Why?
| | Epilepsy | 1 | 2014 | 278 | 0.340 |
Why?
| | Genome-Wide Association Study | 3 | 2023 | 1177 | 0.290 |
Why?
| | Registries | 1 | 2014 | 1768 | 0.260 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2022 | 1880 | 0.240 |
Why?
| | Arthritis, Rheumatoid | 2 | 2024 | 1003 | 0.230 |
Why?
| | Genotype | 5 | 2016 | 1760 | 0.210 |
Why?
| | Whole Genome Sequencing | 1 | 2023 | 94 | 0.210 |
Why?
| | Genetic Association Studies | 3 | 2015 | 339 | 0.200 |
Why?
| | Signal Transduction | 1 | 2015 | 4515 | 0.200 |
Why?
| | Exome | 1 | 2023 | 200 | 0.200 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2022 | 86 | 0.180 |
Why?
| | Risk | 2 | 2014 | 812 | 0.180 |
Why?
| | Lung | 6 | 2023 | 3561 | 0.170 |
Why?
| | Aged | 7 | 2022 | 19074 | 0.160 |
Why?
| | Genetic Variation | 2 | 2015 | 870 | 0.140 |
Why?
| | Middle Aged | 7 | 2022 | 26738 | 0.140 |
Why?
| | Tomography, X-Ray Computed | 3 | 2016 | 2286 | 0.130 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 1131 | 0.120 |
Why?
| | Republic of Korea | 1 | 2015 | 27 | 0.120 |
Why?
| | Humans | 16 | 2024 | 114699 | 0.120 |
Why?
| | Mexico | 1 | 2015 | 162 | 0.120 |
Why?
| | Minnesota | 1 | 2014 | 134 | 0.110 |
Why?
| | Phenotype | 3 | 2022 | 2797 | 0.110 |
Why?
| | Incidence | 2 | 2023 | 2313 | 0.110 |
Why?
| | Carbon Monoxide | 1 | 2012 | 64 | 0.100 |
Why?
| | Male | 8 | 2022 | 55606 | 0.100 |
Why?
| | Vital Capacity | 1 | 2012 | 255 | 0.100 |
Why?
| | Cohort Studies | 3 | 2023 | 4895 | 0.100 |
Why?
| | Case-Control Studies | 3 | 2013 | 3003 | 0.100 |
Why?
| | Genetic Loci | 1 | 2013 | 262 | 0.100 |
Why?
| | Gene Frequency | 3 | 2022 | 477 | 0.100 |
Why?
| | Female | 8 | 2022 | 59520 | 0.090 |
Why?
| | Risk Factors | 4 | 2023 | 8632 | 0.090 |
Why?
| | Survival Analysis | 1 | 2013 | 1211 | 0.090 |
Why?
| | Logistic Models | 1 | 2015 | 1841 | 0.080 |
Why?
| | Disease | 1 | 2009 | 85 | 0.080 |
Why?
| | Long QT Syndrome | 1 | 2009 | 59 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2009 | 487 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 367 | 0.070 |
Why?
| | Genetic Markers | 2 | 2022 | 320 | 0.060 |
Why?
| | Smoking | 2 | 2024 | 1383 | 0.060 |
Why?
| | Adult | 3 | 2022 | 30553 | 0.060 |
Why?
| | Telomere Shortening | 1 | 2024 | 17 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2014 | 5047 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2014 | 6347 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2023 | 12555 | 0.050 |
Why?
| | Telomere | 1 | 2024 | 202 | 0.050 |
Why?
| | Dyspnea | 1 | 2023 | 211 | 0.050 |
Why?
| | Infant | 1 | 2014 | 7964 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2022 | 217 | 0.050 |
Why?
| | Child, Preschool | 1 | 2014 | 9118 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 453 | 0.040 |
Why?
| | Young Adult | 1 | 2014 | 10471 | 0.040 |
Why?
| | Mutation | 2 | 2022 | 3346 | 0.030 |
Why?
| | Adolescent | 1 | 2014 | 17853 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2251 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 251 | 0.030 |
Why?
| | Child | 1 | 2014 | 18420 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2013 | 39 | 0.030 |
Why?
| | Alleles | 1 | 2016 | 789 | 0.030 |
Why?
| | Prospective Studies | 1 | 2022 | 6220 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 723 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1796 | 0.020 |
Why?
| | Sampling Studies | 1 | 2009 | 93 | 0.020 |
Why?
| | Death, Sudden | 1 | 2009 | 27 | 0.020 |
Why?
| | Genes | 1 | 2009 | 223 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 245 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1421 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2009 | 279 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2009 | 515 | 0.020 |
Why?
| | Family | 1 | 2009 | 589 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1693 | 0.020 |
Why?
|
|
Peljto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|